Intravitreal ranibizumab in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy

2010 ◽  
Vol 45 (3) ◽  
pp. 300-301 ◽  
Author(s):  
Andrea K. Leung ◽  
Daniel J. Weisbrod ◽  
Carol Schwartz
Keyword(s):  
Choroidal Neovascular Membrane ◽  
Intravitreal Ranibizumab ◽  
Punctate Inner Choroidopathy

Intravitreal ranibizumab (Lucentis®) in the treatment of choroidal neovascular membrane secondary to punctate inner choroidopathy

2010 ◽  
Vol 85 (4) ◽  
pp. 149-152
Author(s):  
A. Valverde Megías ◽  
P. Arriola Villalobos ◽  
J. Reche Frutos ◽  
J. Donate López ◽  
C. Calvo González ◽  
...  
Keyword(s):  
Choroidal Neovascular Membrane ◽  
Intravitreal Ranibizumab ◽  
Punctate Inner Choroidopathy

scholarly journals Morphologic Changes in Patient with Drusen and Drusenoid Pigment Epithelial Detachment after Intravitreal Ranibizumab for Choroidal Neovascular Membrane : A Case Report

2016 ◽  
Vol 10 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Sukjin Kim ◽  
Jeongjae Oh ◽  
Kiseok Kim
Keyword(s):  
Visual Acuity ◽  
Case Report ◽  
Age Related Macular Degeneration ◽  
Pigment Epithelial Detachment ◽  
Choroidal Neovascular Membrane ◽  
Intravitreal Ranibizumab ◽  
Pigment Epithelial ◽  
Age Related ◽  
The Right ◽  
Morphologic Changes

The authors present a case of morphologic changes of drusen and drusenoid pigment epithelial detachment (DPED) after treating choroidal neovascularization (CNV) using ranibizumab in age-related macular degeneration (AMD). A 71-year-old woman has noticed mild visual acuity deterioration in the right eye for several months. She was presented with some drusen and DPED associated with CNV. This patient was given intravitreal injection of 0.5 mg of ranibizumab five times at monthly intervals for treating CNV. DPED in the temporal and drusen in the superior to macula were diminished, which continued up to 2 months. Intravitreal ranibizumab injection may have influenced with diminishment of drusen and DPED. After 2 months, CNV was recurred.

Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy

2011 ◽  
Vol 89 (s248) ◽  
pp. 0-0
Author(s):  
D PEREZ GARCIA ◽  
I PINILLA ◽  
B JIMENEZ DEL RIO ◽  
J IBANEZ ◽  
C PEIRO EMBID ◽  
...  
Keyword(s):  
Intravitreal Ranibizumab ◽  
Punctate Inner Choroidopathy ◽  
Subretinal Neovascularization

scholarly journals Swept Source-Optical Coherence Tomography Angiography for Management of Secondary Choroidal Neovascularization in Punctate Inner Choroidopathy

2021 ◽  
pp. 232-238
Author(s):  
Martin Stattin ◽  
Julia Forster ◽  
Daniel Ahmed ◽  
Katharina Krepler ◽  
Siamak Ansari-Shahrezaei
Keyword(s):  
Optical Coherence Tomography ◽  
Choroidal Neovascularization ◽  
Optical Coherence Tomography Angiography ◽  
Optical Coherence ◽  
Intravitreal Ranibizumab ◽  
Swept Source ◽  
Punctate Inner Choroidopathy ◽  
White Dot Syndrome ◽  
Oral Corticosteroids ◽  
Sd Oct

The purpose was to demonstrate the diagnostic and therapeutic feasibility of swept source-optical coherence tomography angiography (SS-OCTA) by picturing neovascular changes secondary to a rare white dot syndrome following long-term intravitreal ranibizumab (IVR). A 28-year-old Caucasian myopic female presented with visual loss in her right eye only. The clinical examination and multimodal imaging including spectral domain (SD)-OCT, blue-peak autofluorescence, fluorescein, and indocyanine green angiography (HRA Spectralis, Heidelberg Engineering; Heidelberg, Germany) as well as SS-OCTA (DRI Triton, Topcon; Tokyo, Japan) led to the diagnosis of idiopathic punctate inner choroidopathy with secondary subfoveal choroidal neovascularization (CNV). In addition to oral corticosteroids, a pro re nata regimen with IVR was initiated and guided by repeated SD-OCT and SS-OCTA. Six IVR were administered based on functional SS-OCTA en face scans illustrating vessel transformation and downsizing of the CNV area while SD-OCT B-scans were inconclusive as indirect signs of activity were absent throughout the follow-up period. SS-OCTA provided new possibilities for monitoring vessel development. IVR was managed based on vessel density as displayed by SS-OCTA.

Sign in / Sign up

Export Citation Format

Share Document